Medicamentos Inyectables 3
PROVEER MEDICAMENTOS A PACIENTES BENEFICIARIOS DEL HBSJO
15 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1063535-6727-SE26 | 01-07-2026 | Laboratorio Biosano S.A. | $606.900 |
| 1063535-6486-SE26 | 03-06-2026 | Laboratorio Biosano S.A. | $2.023.000 |
| 1063535-6455-SE26 | 01-06-2026 | Laboratorio Biosano S.A. | $606.900 |
| 1063535-6402-SE26 | 25-05-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
| 1063535-6332-SE26 | 14-05-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.806.420 |
| 1063535-6143-SE26 | 27-04-2026 | Grifols Chile S.A. | $11.420.430 |
| 1063535-6115-SE26 | 23-04-2026 | Guerbet Chile Limitada | $833.000 |
| 1063535-5874-SE26 | 27-03-2026 | Vitafarma S.A. | $487.900 |
| 1063535-5843-SE26 | 24-03-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
| 1063535-5672-SE26 | 09-03-2026 | Guerbet Chile Limitada | $833.000 |
| 1063535-5589-SE26 | 26-02-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
| 1063535-5522-SE26 | 19-02-2026 | Grifols Chile S.A. | $17.130.645 |
| 1063535-5404-SE26 | 06-02-2026 | Grifols Chile S.A. | $17.130.645 |
| 1063535-5406-SE26 | 06-02-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
| 1063535-5225-SE26 | 20-01-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
| 1063535-16859-SE25 | 10-12-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $602.140 |
| 1063535-16763-SE25 | 01-12-2025 | Grifols Chile S.A. | $17.130.645 |
| 1063535-16695-SE25 | 24-11-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
| 1063535-16519-SE25 | 24-10-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $602.140 |
| 1063535-10314-SE25 | 16-09-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
| 1063535-9729-SE25 | 09-07-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $1.806.420 |
| 1063535-9552-SE25 | 17-06-2025 | Laboratorio Biosano S.A. | $404.600 |
| 1063535-9464-SE25 | 04-06-2025 | Laboratorio Biosano S.A. | $404.600 |
| 1063535-9250-SE25 | 12-05-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
| 1063535-9196-SE25 | 05-05-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
| 1063535-3736-SE25 | 14-03-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $1.204.280 |
Fuente original:ficha mercadopublico.cl
